Premium
Expression of CD64 as a potential marker of neonatal sepsis
Author(s) -
LaysecaEspinosa Esther,
PérezGonzález Luis F.,
TorresMontes Abraham,
Baranda Lourdes,
De La Fuente Hortensia,
Rosenstein Yvonne,
GonzálezAmaro Roberto
Publication year - 2002
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1034/j.1399-3038.2002.01064.x
Subject(s) - cd64 , sepsis , medicine , neonatal sepsis , immunology , tumor necrosis factor alpha , gastroenterology , antigen
The aim of this study was to identify a novel immunological indicator useful for the early diagnosis (through a rapid and single determination) of neonatal sepsis (NS). Peripheral blood samples were taken from 63 neonates, who were classified into four groups: proven NS (n = 17); clinical NS (n = 14); disease without infection (n = 17); and healthy newborns (n = 15). Neutrophil expression of CD64, CD43, CD44, CD50, CD62L and Mac‐1, and plasma levels of interleukin (IL)‐1β, IL‐6, tumor necrosis factor‐α (TNF‐α) and soluble L ‐selectin (sCD62L), were determined. Expression of CD64 was significantly enhanced in the group with proven sepsis and clinical NS compared to newborns without infection (p < 0.05). Eight newborns with proven or clinical sepsis, but only one with disease without infection, showed an increased percentage of CD64 + cells (diagnostic specificity = 96.8%). No significant differences were found in the expression of the other leucocyte differentiation antigens studied. As previously described, TNF‐α and IL‐6 levels were significantly elevated in newborns with proven or clinical sepsis compared to neonates without infection (p < 0.05). Our results suggest that, through a single determination, the enhanced expression of CD64 is a highly specific indicator of NS, although its diagnostic sensitivity is low (25.8%). In contrast, we found that plasma levels of IL‐1β and sCD62L, as well as the expression of Mac‐1, CD43, CD44, CD50, and CD62L, do not appear to be useful for the diagnosis of NS.